Matt Will Market Quotations

Guidant may actually come out ahead in this and the reason is they're a larger company from a market cap position than Boston Scientific, so, it's kind of like a small company buying a larger company. At the end of the day, they may be the dominant company in this merger.

The market insisted that this is the way to go.